GB0711089D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0711089D0
GB0711089D0 GBGB0711089.3A GB0711089A GB0711089D0 GB 0711089 D0 GB0711089 D0 GB 0711089D0 GB 0711089 A GB0711089 A GB 0711089A GB 0711089 D0 GB0711089 D0 GB 0711089D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0711089.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0711089.3A priority Critical patent/GB0711089D0/en
Publication of GB0711089D0 publication Critical patent/GB0711089D0/en
Priority to PCT/EP2008/056961 priority patent/WO2008148832A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
GBGB0711089.3A 2007-06-08 2007-06-08 Compounds Ceased GB0711089D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0711089.3A GB0711089D0 (en) 2007-06-08 2007-06-08 Compounds
PCT/EP2008/056961 WO2008148832A1 (en) 2007-06-08 2008-06-05 Compounds which potentiate ampa receptor and uses therof in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0711089.3A GB0711089D0 (en) 2007-06-08 2007-06-08 Compounds

Publications (1)

Publication Number Publication Date
GB0711089D0 true GB0711089D0 (en) 2007-07-18

Family

ID=38319021

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0711089.3A Ceased GB0711089D0 (en) 2007-06-08 2007-06-08 Compounds

Country Status (2)

Country Link
GB (1) GB0711089D0 (en)
WO (1) WO2008148832A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
KR20170141768A (en) * 2015-04-29 2017-12-26 얀센 파마슈티카 엔.브이. Use of imidazopyrazine and pyrazolopyrimidine and AMPA receptor modulators thereof
CA2984290C (en) 2015-04-29 2022-03-01 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
MX369806B (en) 2015-04-29 2019-11-21 Janssen Pharmaceutica Nv Indolone compounds and their use as ampa receptor modulators.
SI3288940T1 (en) 2015-04-29 2021-07-30 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
GB201702221D0 (en) * 2017-02-10 2017-03-29 Univ Of Sussex Compounds
GB201803340D0 (en) 2018-03-01 2018-04-18 Univ Of Sussex Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005021407D1 (en) * 2004-08-09 2010-07-01 Glaxo Group Ltd Compounds for enhancing glutamate receptor activity and their use in medicine
JP2009531320A (en) * 2006-03-20 2009-09-03 グラクソ グループ リミテッド Compounds that potentiate AMPA receptors and their use in medicine
WO2008053031A1 (en) * 2006-11-03 2008-05-08 Glaxo Group Limited Compounds which potentiate ampa receptor and uses thereof in medicine

Also Published As

Publication number Publication date
WO2008148832A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
GB0706793D0 (en) Compounds
GB0704407D0 (en) Compounds
GB0704394D0 (en) Compounds
GB0705672D0 (en) Compounds
GB0706173D0 (en) Compounds
GB0711089D0 (en) Compounds
GB0707092D0 (en) Compounds
GB0706188D0 (en) Compounds
GB0706168D0 (en) Compounds
GB0706165D0 (en) Compounds
GB0707034D0 (en) Compounds
GB0711088D0 (en) Compounds
GB0706167D0 (en) Compounds
GB0706174D0 (en) Compounds
GB0706187D0 (en) Compounds
GB0706189D0 (en) Compounds
GB0706164D0 (en) Compounds
GB0706190D0 (en) Compounds
GB0706170D0 (en) Compounds
GB0704939D0 (en) Compounds
GB0703756D0 (en) Compounds
GB0701985D0 (en) Compounds
GB0702960D0 (en) Compounds
GB0700286D0 (en) Compounds
GB0703906D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)